home / stock / vcnx / vcnx news

VCNX News and Press, Vaccinex Inc. From 11/13/23

Stock Information
Company Name: Vaccinex Inc.
Stock Symbol: VCNX
Market: NASDAQ
Website: vaccinex.com
Menu
VCNX VCNX Quote VCNX Short VCNX News VCNX Articles VCNX Message Board
Get VCNX Alerts

News, Short Squeeze, Breakout and More Instantly...
VCNX - Expected US Company Earnings on Monday, November 13th, 2023

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
VCNX - Vaccinex Reports Clinical Benefit in Interim Analyses from two Phase 2 Studies of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer's Annual Meeting

ROCHESTER, N.Y., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company, will be reporting novel findings for its lead product, pepinemab, in two presentations at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC), being held...

VCNX - BIVI, VCNX and BHAT among pre-market losers

2023-10-27 08:23:45 ET Losers: PTC Therapeutics PTCT -23% after Q3 earning release . Sanofi SNY -17% after Q3 earning release . Enphase Energy ENPH -17% after Q3 earning release . Jaguar Global Growth Corp I ( JGGC ) -13%. NatWest Group ...

VCNX - Vaccinex Reports Positive Effect of Pepinemab Treatment on New Biomarker of Brain Inflammation in Neurodegenerative Diseases

ROCHESTER, N.Y., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company, today reports novel findings for its lead product, pepinemab, in a highlighted podium presentation at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Bo...
VCNX - BYND, SLS and WHLR among pre-market losers

2023-10-12 08:22:14 ET More on Beyond Meat, SELLAS Life Sciences, etc. Beyond Meat Continues To Look Potentially Beyond Repair Beyond Meat: The Core Question Here Is Liquidity Beyond Meat: Pain Is Far From Over SELLAS gains on FDA orphan drug status for its S...

VCNX - SNMP, HUSA and VCNX among mid-day movers

2023-10-09 12:57:21 ET More on Tian Ruixiang Holdings, Vaccinex, etc. Vaccinex slumps 29%, prices $9.6M equity Financial information for Tian Ruixiang Holdings Financial information for Vaccinex For further details see: SNMP, HUSA and VCNX among mid-day m...

VCNX - 24/7 Market News Lunch Break 6 Oct 2023

2023-10-06 12:23:43 ET DENVER, Colo., Oct 5, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; ParaZero Technologies (NASDAQ: PRZO), NuScale Power (NYSE: SMR), Siyata Mobile Inc. (NASDAQ: SYTA), Vacc...
VCNX - 24/7 Market News Snapshot 6 Oct 2023

2023-10-06 10:09:21 ET DENVER, Colo., Oct 6, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; ParaZero Technologies (NASDAQ: PRZO), NuScale Power (NYSE: SMR), Apellis Pharmaceuticals (NASDAQ: APLS), Athena...

VCNX - Curis, Corcept Therapeutics among healthcare movers

2023-09-29 09:59:40 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) BofA Securities: Which small cap non-earner stocks to avoid Health Care Select Sector SPDR ETF declares quarterly distribution of $0.53...

VCNX - Vaccinex slumps 29%, prices $9.6M equity

2023-09-29 04:38:46 ET More on Vaccinex Financial information for Vaccinex For further details see: Vaccinex slumps 29%, prices $9.6M equity
Previous 10 Next 10